Total Funding: 6000000.0
Headquarters: Paris, Ile-de-France, France
Funding Status: Early Stage Venture
Last Funding Type: Series A
Last Funding Date: 2022-09-02
Investors Number: 5.0
Founded Date: 2019-01-01
Industry: Early Drug Development